Aug 10, 2021

Esendo Fungicide is AgBiome’s next product set for EPA for review

AgBiome, a developer of products from the Earth’s microbial communities, announced Aug. 10 the submission of Esendo Fungicide, its next product, to the EPA for review.

Pending EPA registration, Esendo Fungicide will be the first combination product that AgBiome brings to market and its third product in the last four years.

Esendo Fungicide is a premix that combines Howler Fungicide with the active ingredient azoxystrobin. The combination has multiple modes of action for resistance management and provides activity against a broad spectrum of important diseases. Esendo Fungicide can be used effectively as part of an integrated disease and resistance management program on a wide range of important crops.

“We’re pleased to submit our third product to the EPA,” Jim Spadafora, project lead at AgBiome, said in a news release. “AgBiome continues to develop highly-effective, innovative crop protection products. Growers need new tools to control problematic diseases while ensuring effective resistance management. Esendo Fungicide provides growers access to the combined power of the biological benefits of Howler and a proven synthetic chemistry.”

Esendo fungicide will mark AgBiome’s third fungicide submitted to the EPA to date. AgBiome has developed two biological fungicides, Howler and Theia Fungicide. Howler received EPA approval in the second half of 2017, and has gained individual registration in all 50 U.S. states. Theia Fungicide was submitted for EPA review in December 2019.